# United Bancorp Inc: financial statements, quarterly

UBCP · Nasdaq · CIK 731653 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ubcp.md) · [Financials](/companies/ubcp/financials.md) · [Filings](/companies/ubcp/filings.md) · [Insiders](/companies/ubcp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ubcp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $k | [3,085](/filings/0001410578-24-000239.md) | [3,203](/filings/0001410578-24-000239.md) | [3,506](/filings/0001410578-24-000855.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [58.0](/filings/0001410578-25-000351.md) | [202](/filings/0001410578-25-000351.md) | [150](/filings/0001104659-26-030899.md) | [(127)](/filings/0001104659-26-030899.md) | [(64.0)](/filings/0001104659-26-030899.md) | [(66.0)](/filings/0001104659-26-030899.md) | [(26.0)](/filings/0001104659-26-060924.md) | [22.0](/filings/0001104659-26-094756.md) | [(20.0)](/filings/0001104659-26-030899.md) | [(62.0)](/filings/0001104659-26-030899.md) | [(160)](/filings/0001104659-26-060924.md) | [(34.0)](/filings/0001104659-26-094756.md) |
| Net income | $k | [2,392](/filings/0001410578-25-000351.md) | [2,390](/filings/0001410578-25-000351.md) | [1,993](/filings/0001104659-26-030899.md) | [1,740](/filings/0001104659-26-030899.md) | [1,820](/filings/0001104659-26-030899.md) | [1,849](/filings/0001104659-26-030899.md) | [1,872](/filings/0001104659-26-060924.md) | [1,914](/filings/0001104659-26-094756.md) | [1,931](/filings/0001104659-26-030899.md) | [2,036](/filings/0001104659-26-030899.md) | [1,911](/filings/0001104659-26-060924.md) | [2,095](/filings/0001104659-26-094756.md) |
| Diluted EPS | $ per share | [0.42](/filings/0001410578-25-000351.md) | [0.42](/filings/0001410578-25-000351.md) | [0.35](/filings/0001104659-26-030899.md) | [0.30](/filings/0001104659-26-030899.md) | [0.31](/filings/0001104659-26-030899.md) | [0.31](/filings/0001104659-26-030899.md) | [0.32](/filings/0001104659-26-060924.md) | [0.33](/filings/0001104659-26-094756.md) | [0.34](/filings/0001104659-26-030899.md) | [0.35](/filings/0001104659-26-030899.md) | [0.33](/filings/0001104659-26-060924.md) | [0.36](/filings/0001104659-26-094756.md) |
| Basic EPS | $ per share | [0.42](/filings/0001410578-25-000351.md) | [0.42](/filings/0001410578-25-000351.md) | [0.35](/filings/0001104659-26-030899.md) | [0.30](/filings/0001104659-26-030899.md) | [0.31](/filings/0001104659-26-030899.md) | [0.31](/filings/0001104659-26-030899.md) | [0.32](/filings/0001104659-26-060924.md) | [0.33](/filings/0001104659-26-094756.md) | [0.34](/filings/0001104659-26-030899.md) | [0.35](/filings/0001104659-26-030899.md) | [0.33](/filings/0001104659-26-060924.md) | [0.36](/filings/0001104659-26-094756.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [40.8](/filings/0001410578-25-000351.md) | [46.9](/filings/0001410578-24-000855.md) | [37.6](/filings/0001410578-24-001349.md) | [37.8](/filings/0001410578-24-001918.md) | [19.6](/filings/0001104659-26-030899.md) | [36.4](/filings/0001410578-25-001248.md) | [49.7](/filings/0001410578-25-001789.md) | [45.7](/filings/0001104659-25-110121.md) | [46.5](/filings/0001104659-26-030899.md) | not reported | not reported |
| Total assets | $m | [814](/filings/0001410578-23-002445.md) | [819](/filings/0001410578-25-000351.md) | [834](/filings/0001410578-24-000855.md) | [822](/filings/0001410578-24-001349.md) | [825](/filings/0001410578-24-001918.md) | [817](/filings/0001104659-26-030899.md) | [831](/filings/0001410578-25-001248.md) | [848](/filings/0001410578-25-001789.md) | [867](/filings/0001104659-25-110121.md) | [857](/filings/0001104659-26-094756.md) | [858](/filings/0001104659-26-060924.md) | [878](/filings/0001104659-26-094756.md) |
| Total liabilities | $m | [762](/filings/0001410578-23-002445.md) | [756](/filings/0001410578-25-000351.md) | [771](/filings/0001410578-24-000855.md) | [761](/filings/0001410578-24-001349.md) | [760](/filings/0001410578-24-001918.md) | [753](/filings/0001104659-26-030899.md) | [770](/filings/0001410578-25-001248.md) | [788](/filings/0001410578-25-001789.md) | [800](/filings/0001104659-25-110121.md) | [787](/filings/0001104659-26-094756.md) | [791](/filings/0001104659-26-060924.md) | [806](/filings/0001104659-26-094756.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [52.6](/filings/0001410578-24-001918.md) | [63.6](/filings/0001104659-26-030899.md) | [63.2](/filings/0001410578-25-001789.md) | [60.6](/filings/0001104659-25-110121.md) | [65.5](/filings/0001104659-25-110121.md) | [63.5](/filings/0001104659-26-094756.md) | [60.8](/filings/0001104659-26-094756.md) | [59.7](/filings/0001104659-26-094756.md) | [66.5](/filings/0001104659-25-110121.md) | [70.5](/filings/0001104659-26-094756.md) | [67.5](/filings/0001104659-26-094756.md) | [72.1](/filings/0001104659-26-094756.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,118 d](/filings/0001410578-24-001918.md) | [2,715 d](/filings/0001410578-25-000351.md) | [3,615](/filings/0001410578-25-001248.md) | [(789) d](/filings/0001410578-25-001789.md) | [4,410 d](/filings/0001104659-25-110121.md) | [1,212 d](/filings/0001104659-26-030899.md) | [1,064](/filings/0001104659-26-060924.md) | [3,781 d](/filings/0001104659-26-094756.md) | [3,165 d](/filings/0001104659-25-110121.md) | [2,446 d](/filings/0001104659-26-030899.md) | [266](/filings/0001104659-26-060924.md) | [1,036 d](/filings/0001104659-26-094756.md) |
| Capital expenditure | $k | [426 d](/filings/0001410578-24-001918.md) | [129 d](/filings/0001410578-25-000351.md) | [3,392](/filings/0001410578-25-001248.md) | [727 d](/filings/0001410578-25-001789.md) | [6,091 d](/filings/0001104659-25-110121.md) | [(515) d](/filings/0001104659-26-030899.md) | [1,658](/filings/0001104659-26-060924.md) | [2,317 d](/filings/0001104659-26-094756.md) | [3,532 d](/filings/0001104659-25-110121.md) | [4,271 d](/filings/0001104659-26-030899.md) | [2,044](/filings/0001104659-26-060924.md) | [1,176 d](/filings/0001104659-26-094756.md) |
| Dividends paid | $k | [986 d](/filings/0001410578-24-001918.md) | [1,003 d](/filings/0001410578-25-000351.md) | [1,938](/filings/0001410578-25-001248.md) | [1,041 d](/filings/0001410578-25-001789.md) | [1,061 d](/filings/0001104659-25-110121.md) | [1,073 d](/filings/0001104659-26-030899.md) | [2,133](/filings/0001104659-26-060924.md) | [1,104 d](/filings/0001104659-26-094756.md) | [1,117 d](/filings/0001104659-25-110121.md) | [1,130 d](/filings/0001104659-26-030899.md) | [2,196](/filings/0001104659-26-060924.md) | [1,162 d](/filings/0001104659-26-094756.md) |
| Share repurchases | $k | [0.0 d](/filings/0001410578-24-001918.md) | [0.0 d](/filings/0001410578-25-000351.md) | [656](/filings/0001410578-25-001248.md) | [15.0 d](/filings/0001410578-25-001789.md) | [16.0 d](/filings/0001104659-25-110121.md) | [0.0 d](/filings/0001104659-26-030899.md) | [49.0](/filings/0001104659-26-060924.md) | [80.0 d](/filings/0001104659-26-094756.md) | [0.0 d](/filings/0001104659-25-110121.md) | [188 d](/filings/0001104659-26-030899.md) | [374](/filings/0001104659-26-060924.md) | [342 d](/filings/0001104659-26-094756.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,488](/filings/0001410578-23-002445.md) | [5,485](/filings/0001410578-24-000855.md) | [5,496](/filings/0001410578-24-001349.md) | [5,489](/filings/0001410578-24-001918.md) | [5,500](/filings/0001410578-25-001248.md) | [5,630](/filings/0001410578-25-001789.md) | [5,621](/filings/0001104659-25-110121.md) | [5,566](/filings/0001104659-26-060924.md) | [5,491](/filings/0001104659-26-094756.md) | [5,486](/filings/0001104659-25-110121.md) | [5,497](/filings/0001104659-26-060924.md) | [5,473](/filings/0001104659-26-094756.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,735,518 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001104659-26-094756.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.